Caribou Biosciences Inc (CRBU) Stock Price, Quote & News

Company Profile

Caribou Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the development of genome-edited allogeneic cell therapies for the treatment of hematologic malignancies and autoimmune diseases in the United States and internationally. The company's lead product candidate include CB-010, an allogeneic anti-CD19 CAR-T cell therapy that is in phase 1 clinical trial to treat relapsed or refractory B cell non-Hodgkin lymphoma, refractory systemic lupus erythematosus, lupus nephritis...

Industry: Biotechnology

Sector: Healthcare

Phone: 510 982 6030

Website: cariboubio.com

Address:

2929 7th Street, Suite 105, Berkeley, United States

Bio_Be_Dirty Feb. 4 at 5:26 AM

$CRBU hmm

0 · Reply

Megabyte48 Feb. 4 at 1:06 AM

$CRBU Looking good for tomorrow. Breakout if she holds this time over 1.70.

0 · Reply

RunnerSignals Feb. 3 at 10:03 PM

today top upgrades in the BUZZ $CRBU $FDX $GFI $COST $CMCSA Whether it's biotech sparks or retail royalty, these upgrades are also shifting the narrative today https://stocksrunner.com/news/2026-02-03-top-stock-upgrades-today

0 · Reply

showmetheoilcash Feb. 3 at 8:57 PM

$CRBU holding for $20

0 · Reply

showmetheoilcash Feb. 3 at 3:40 PM

$CRBU $15

1 · Reply

Peterson28 Feb. 3 at 3:33 PM

$CRBU No love again. Round tripped.

0 · Reply

notreload_ai Feb. 2 at 11:14 PM

Clear Street initiates coverage of $CRBU with a Buy rating and a $13 price target, highlighting strong CAR-T pipeline potential https://notreload.xyz/clear-street-starts-coverage-on-caribou-biosciences-with-buy-rating/

2 · Reply

Rolo2024 Feb. 2 at 10:07 PM

$CRBU PT $10.88 plenty of time to hop on board for s great investment and reward. Easily double by April 15th.

1 · Reply

Rolo2024 Feb. 2 at 9:40 PM

$CRBU This is the begginning! Accumulate low while you can or average down.

0 · Reply

Peterson28 Jan. 31 at 11:39 PM

$CRBU Market is entering a deleveraging crash. XBI can correct 50%. This thing can drop 80% if we have a systemic risk crash. Rachel still hasn’t figured out how to fund Phase 3. No time for the management to waste time. Sell it if you are incapable.

1 · Reply

Caribou Biosciences to Host In-Person and Virtual KOL Event at ASH 2025

Nov 12, 2025, 4:05 PM EST - 2 months ago

Caribou Biosciences Reports Third Quarter 2025 Financial Results and Provides Business Update

Nov 3, 2025, 5:15 PM EST - 3 months ago

Caribou Biosciences to Participate in Upcoming Investor Conferences

Nov 3, 2025, 11:48 AM EST - 3 months ago

Why Is CRISPR Genome-Editing Firm Caribou Biosciences Stock Trading Higher Today>

Nov 3, 2025, 7:00 AM EST - 3 months ago

Caribou Biosciences Announces Positive Data from CaMMouflage Phase 1 Trial of CB-011 in Multiple Myeloma

Nov 3, 2025, 7:00 AM EST - 3 months ago

Caribou Biosciences Announces Positive Data from ANTLER Phase 1 Trial Demonstrating Efficacy and Durability of Vispa-cel (CB-010), an Allogeneic CAR-T Cell Therapy, on Par with Autologous CAR-T Cell Therapies

Nov 2, 2025, 4:00 PM EST - 3 months ago

Caribou Biosciences to Host Webcast to Report New Data Updates from Two Allogeneic CAR-T Cell Therapy Programs in Lymphoma and Multiple Myeloma

Aug 25, 2025, 4:05 PM EDT - 5 months ago

Caribou Biosciences to Participate in the Citi 2025 Biopharma Back to School Conference

Aug 12, 2025, 4:05 PM EDT - 6 months ago

Caribou Biosciences Reports Second Quarter 2025 Financial Results and Provides Business Update

May 28, 2025, 4:00 PM EDT - 8 months ago

Caribou Biosciences to Participate in the Jefferies Global Healthcare Conference

May 8, 2025, 4:05 PM EDT - 9 months ago

Caribou Biosciences Reports First Quarter 2025 Financial Results and Provides Business Update

May 6, 2025, 4:00 PM EDT - 9 months ago

Caribou Biosciences to Participate in the BofA Securities 2025 Health Care Conference

Apr 24, 2025, 4:15 PM EDT - 10 months ago

Caribou Biosciences Announces Strategic Pipeline Prioritization with Focus on CB-010 and CB-011 Oncology Programs

Apr 10, 2025, 10:00 AM EDT - 10 months ago

Bronstein, Gewirtz & Grossman, LLC Is Investigating Caribou Biosciences, Inc. (CRBU) And Encourages Shareholders to Connect

Apr 8, 2025, 10:00 AM EDT - 10 months ago

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Caribou Biosciences, Inc. (CRBU) And Encourages Shareholders to Reach Out

Apr 6, 2025, 10:00 AM EDT - 10 months ago

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Caribou Biosciences, Inc. (CRBU) and Encourages Shareholders to Learn More About the Investigation

Apr 3, 2025, 10:00 AM EDT - 10 months ago

Caribou Biosciences, Inc. (CRBU) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation

Apr 1, 2025, 10:00 AM EDT - 11 months ago

Caribou Biosciences, Inc. (CRBU) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation

Mar 30, 2025, 10:00 AM EDT - 11 months ago

Bronstein, Gewirtz & Grossman, LLC Is Investigating Caribou Biosciences, Inc. (CRBU) And Encourages Investors to Connect

Mar 27, 2025, 10:00 AM EDT - 11 months ago

Bronstein, Gewirtz & Grossman, LLC Encourages Caribou Biosciences, Inc. (CRBU) Stockholders to Inquire about Securities Investigation

Mar 25, 2025, 10:00 AM EDT - 11 months ago

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Caribou Biosciences, Inc. (CRBU) and Encourages Investors to Learn More About the Investigation

Mar 20, 2025, 10:00 AM EDT - 11 months ago

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Caribou Biosciences, Inc. (CRBU) And Encourages Stockholders to Reach Out

Mar 18, 2025, 10:00 AM EDT - 11 months ago

Bronstein, Gewirtz & Grossman, LLC Is Investigating Caribou Biosciences, Inc. (CRBU) And Encourages Stockholders to Connect

Mar 16, 2025, 10:00 AM EDT - 11 months ago

Caribou Biosciences, Inc. (CRBU) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation

Mar 13, 2025, 10:00 AM EDT - 11 months ago

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Caribou Biosciences, Inc. (CRBU) and Encourages Stockholders to Learn More About the Investigation

Mar 11, 2025, 10:00 AM EDT - 11 months ago

Bronstein, Gewirtz & Grossman, LLC Encourages Caribou Biosciences, Inc. (CRBU) Investors to Inquire about Securities Investigation

Mar 10, 2025, 4:05 PM EDT - 11 months ago

Caribou Biosciences Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update

Feb 24, 2025, 5:45 AM EST - 1 year ago

Shareholders of Caribou Biosciences, Inc. Should Contact The Gross Law Firm Before February 24, 2025 to Discuss Your Rights - CRBU

Feb 23, 2025, 9:27 AM EST - 1 year ago

INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Caribou Biosciences

Feb 20, 2025, 1:28 PM EST - 1 year ago

The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of February 24, 2025 in Caribou Biosciences, Inc. Lawsuit – CRBU

Feb 19, 2025, 10:22 AM EST - 1 year ago

SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Caribou Biosciences

Feb 15, 2025, 3:04 PM EST - 1 year ago

CRBU Deadline: Rosen Law Firm Urges Caribou Biosciences, Inc. (NASDAQ: CRBU) Investors to Contact the Firm for Information About Their Rights

Jan 29, 2025, 10:51 AM EST - 1 year ago

DEADLINE REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Caribou Biosciences

Bio_Be_Dirty Feb. 4 at 5:26 AM

$CRBU hmm

0 · Reply

Megabyte48 Feb. 4 at 1:06 AM

$CRBU Looking good for tomorrow. Breakout if she holds this time over 1.70.

0 · Reply

RunnerSignals Feb. 3 at 10:03 PM

0 · Reply

showmetheoilcash Feb. 3 at 8:57 PM

$CRBU holding for $20

0 · Reply

showmetheoilcash Feb. 3 at 3:40 PM

$CRBU $15

1 · Reply

Peterson28 Feb. 3 at 3:33 PM

$CRBU No love again. Round tripped.

0 · Reply

notreload_ai Feb. 2 at 11:14 PM

2 · Reply

Rolo2024 Feb. 2 at 10:07 PM

$CRBU PT $10.88 plenty of time to hop on board for s great investment and reward. Easily double by April 15th.

1 · Reply

Rolo2024 Feb. 2 at 9:40 PM

$CRBU This is the begginning! Accumulate low while you can or average down.

0 · Reply

Peterson28 Jan. 31 at 11:39 PM

1 · Reply

Peterson28 Jan. 27 at 9:49 PM

$CRBU Someone placed 6 figure sell orders at 1.65 to cap the upside. Why?

1 · Reply

3DBuilds Jan. 27 at 2:22 PM

$CRBU Oh Jennifer 💯

0 · Reply

theBigDollarski Jan. 26 at 9:43 PM

$CRBU finally dumped for a loss..making too much in other names...held for 2 years..Rachel is driving this company into the dirt

3 · Reply

3DBuilds Jan. 24 at 2:25 AM

$CRBU I found a good article 💯 💰 🌎

1 · Reply

hitmongreen Jan. 22 at 4:32 PM

$CRBU need more here

0 · Reply

RocroBio Jan. 21 at 10:31 PM

$CRBU

0 · Reply

RocroBio Jan. 21 at 10:28 PM

$CRBU careful right now super volatile

0 · Reply

MoreBags4Me Jan. 21 at 10:19 PM

$CRBU Almost looks like a good entry point here.

0 · Reply

ChicagoJoe20 Jan. 21 at 12:58 AM

$CRBU $SPY dip into a low interest credit card to make big bucks in the "no one loses" casino. Then pay back the cheap credit card. Interest rates are going up on the cheap credit card now. ~the more you

2 · Reply

Jidane Jan. 21 at 12:01 AM

$CRBU $SPY what’s happening inJapan? It affects U.S treaury rate.

0 · Reply

Peterson28 Jan. 20 at 8:38 PM

$CRBU That’s the reason why it dropped below the 250MA after Rachel opened her month. No BO and no funding update neither.

1 · Reply

steven1x Jan. 18 at 9:17 PM

$CRBU whose going to partner? https://copilot.microsoft.com/shares/mXYGoqJAgFoybj9SUm5rU

3 · Reply

Market Cap	131.79M
Revenue (ttm)	9.99M
Net Income (ttm)	-149.11M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-1,492.59%
Debt to Equity Ratio	0.00

Volume	2,390,500
Avg Vol	1,046,652
Day's Range	N/A - N/A
Shares Out	93.47M
Stochastic %K	50%
Beta	2.61
Analysts	Strong Sell
Price Target	$10.88